Ocugen, Inc. — Director's Dealing 2022

Mar 24, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Ocugen, Inc. (OCGN)
CIK: 0001372299
Period of Report: 2022-03-21

Reporting Person: WHITTINGTON MARNA C (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-03-21	Option (Right to Buy)	$3.72	A	106383	Acquired	2032-03-21	Common Stock (106383)	Direct

Footnotes

F1: The option vests monthly in equal installments over three years commencing on April 21, 2022, subject to continued service with Ocugen, Inc. through the applicable vesting dates.